BostonGene Funding & Investors
Waltham, MA
BostonGene Corporation is pioneering the use of biomedical software for advanced patient analysis and personalized therapy decision making in the fight against cancer. BostonGene’s unique solution performs sophisticated analytics to aid clinicians in their evaluation of viable treatment options for each patient's individual genetics, tumor and tumor microenvironment, clinical characteristics and disease profile. BostonGene’s mission is to enable physicians to provide every patient with the highest probability of survival through optimal cancer treatments using advanced, personalized therapies
https://bostongene.com/Total Amount Raised: $200,000,000
BostonGene Funding Rounds
Series B
$150,000,000
Series B Investors
NECJapan Industrial PartnersImpact Investment CapitalSeries A
$50,000,000
Series A Investors
NEC
Funding info provided by Diffbot.